http://www.halozyme.com
Halozyme Therapeutics, Inc. Company Intro
Industry
Healthcare
Halozyme Therapeutics, Inc. Headquaters
11388 Sorrento Valley Road
San Diego,92121
United States
Halozyme Therapeutics, Inc. Share price
22 Jan 2021 01:47 GMT
$48.37
0.7 (1.47 %)
Halozyme Therapeutics, Inc. Market cap
$6.421 B
WMC RANKING
2021
Halozyme Therapeutics, Inc. # 40
BiotechnologyLatest Halozyme Therapeutics, Inc. News
19 Jan 2021
Pertuzumab Market Future Challenges and Analysis 2026 | Halozyme Therapeutics, Inc. and F. Hoffmann-La Roche Ltd.
Major Players included in this report are as follows – Halozyme Therapeutics, Inc. and F. Hoffmann-La Roche Ltd. Get PDF Brochure Of This Research Report @ ...
16 Jan 2021
Halozyme Announces Janssen Receives FDA Approval Of DARZALEX FASPRO® (Daratumumab And Hyaluronidase-fihj) As Treatment For Newly Diagnosed Patients With Light Chain (AL) Amyloidosis
15, 2021 /PRNewswire/ -- Halozyme Therapeutics, Inc. (NASDAQ: HALO) today announced that Janssen Biotech, Inc. (Janssen) has received U.S. Food and ...
16 Jan 2021
Global Antidiabetics Market Analytical Report 2021 – Covid ...
The company profile covers end-user applications, channel analysis, competitive landscape overview, and expansion plans. It presents industry plans and ...
WMC Market Score
WMC Market to Revenue Score
Halozyme Therapeutics, Inc. Market Financials
Revenue, Expenses, Profit
| Company | Currency | Revenue | Expense | Profit | Market Cap | WMC Sector Score |
| Halozyme Therapeutics, Inc. | USD | $199,556 | $131,205 | $21,524 | $64,210B | 40 |
| Regeneron Pharmaceuticals, Inc. | USD | $9,243,500 | $5,152,600 | $3,156,000 | $571,390B | 1 |
| Alexion Pharmaceuticals, Inc. | USD | $5,862,400 | $2,588,400 | $956,600 | $345,270B | 2 |
| Vertex Pharmaceuticals Incorporated | USD | $5,991,128 | $2,596,854 | $2,690,691 | $620,550B | 3 |
| ALK-Abello A/S | USD | $3,383,000 | $1,831,000 | $43,000 | $271,640B | 4 |
Market Analytics
Company Search vs Top 4 Industry Competitors
Total Halozyme Therapeutics, Inc. Social Followers vs Top 4 Industry Competitors
Halozyme Therapeutics, Inc. Post vs Top 4 Industry Competitors
Halozyme Therapeutics, Inc. Digital Footprint By Size vs Top 4 Industry Competitors
Halozyme Therapeutics, Inc. Digital Footprint By Change Rate vs Top 4 Industry Competitors
Halozyme Therapeutics, Inc. WMC Market Score Calculations
| Details | Revenue | Total Social Followers | Total Social Posts | Search Volume | Digital Footprint Size | Digital change (New Pages) | WMC Market Score |
| Halozyme Therapeutics, Inc. | 2.16 | 0.16 | 1.25 | 0 | 0 | 0 | 0.72 |
| Regeneron Pharmaceuticals, Inc. | 100 | 66.33 | 29.44 | 100 | 0 | 0 | 100 |
| Alexion Pharmaceuticals, Inc. | 63.42 | 16.28 | 100 | 60 | 0 | 0 | 90.10 |
| Vertex Pharmaceuticals Incorporated | 64.81 | 100 | 8.77 | 86 | 0 | 0 | 99.40 |
| ALK-Abello A/S | 36.60 | 0 | 0 | 0 | 0 | 0 | 0 |
Book a demo
Book a free one-on-one demo with one of our team and see exactly how the WMC business intelligence platform can help you protect and grow revenue.
* required fields
You'll learn how to:
- 1. Automatically monitor your entire digital landscape including competitors
- 2. View all new industry activity in real time
- 3. Monitor your position in your industry
- 4. Enrich your reports and strategy
- 5. Empower your teams with knowledge
